Results from a small study indicate patients with difficult-to-treat diabetic peripheral neuropathy (DPN) may benefit from therapy with tanezumab, a humanized monoclonal antibody against nerve growth factor.
Only half of all patients who report experiencing symptoms that would fulfill migraine diagnostic criteria have received a formal migraine diagnosis from a physician.
Pregnant women should steer clear of certain migraine prevention medications which have been associated with decreased IQ scores in children exposed to them in utero.
Prenatal exposure to polybrominated diphenyl ethers (PBDEs) is associated with cognitive deficits and hyperactivity in young children.
Although most high school athletes are knowledgeable about concussion, most seem unwilling to report symptoms immediately or to abstain from play.
Analysis of claims data finds patients often receive starting doses of Butrans that do not follow published recommendations, with more than one-third of patients receiving initial doses that are too low.
Though the third edition of the International Classification of Headache Disorders (ICHD-III) proposes to label aura in non-hemiplegic migraine that lasts longer than one hour but shorter than one week as probable migraine with aura — or probable complex migraine — a group of researchers from Italy, Switzerland, Germany, and California decided to analyze clinical studies to determine whether or not that timeframe aligns with the typical duration of migraine aura.
Patients with Cushing's syndrome have abnormal brain metabolites suggestive of neuronal dysfunction even after they appeared to have been cured.
Older adults who play a video game to improve their visual speed of processing have stable or improved cognitive function.
For children with autism spectrum disorder (ASD), a robot co-therapist may improve targeted behaviors; and communication can be enhanced with augmentative alternative communication (AAC) devices.